Previous Article | Next Article ![]()
Infection and Immunity, October 1999, p. 5483-5485, Vol. 67, No. 10
The Trudeau Institute, Saranac Lake, New York
12983
Received 12 May 1999/Returned for modification 14 June
1999/Accepted 13 July 1999
The CDC1551 strain of Mycobacterium tuberculosis was
compared with the H37Rv strain of M. tuberculosis and the
Ravenel strain of Mycobacterium bovis for virulence in
mice. Although all three strains gave rise to the same level of
stationary infection in major organs, mice infected with the Ravenel
strain died much earlier from lung disease.
A recently isolated strain of
Mycobacterium tuberculosis (CDC1551) responsible for a
relatively large number cases of active tuberculosis in a small
geographical area near the Kentucky-Tennessee border was shown to have
a greatly faster doubling time in the lungs of mice than the long
established Erdman strain (14). It was reasoned, on the
basis of this finding, that strain CDC1551 has a very high virulence
for mice and that this could indicate that it has a high virulence for
humans, which would explain, in turn, its unusually high
transmissibility. This seems a reasonable interpretation, given that
the communicability of tuberculosis depends on the ability of M. tuberculosis to cause lung pathology. On the other hand, the
communicability of a pathogen can depend on properties other than
virulence, such as an ability to resist desiccation. It seemed
important to determine, therefore, whether the reported superior
ability of CDC1551 to multiply in the lungs of mice over a relatively
short period of observation is associated with a superior ability to
cause disease.
To investigate this, 10-week-old male C57BL/6 mice (Jackson
Laboratories, Bar Harbor, Maine) were infected via the respiratory route in an aerosol infection apparatus, as previously described (6), with approximately 102 CFU of M. tuberculosis H37Rv, Mycobacterium bovis Ravenel (TMC 102 and TMC 401; originally obtained from the Trudeau Mycobacterial Culture Collection and currently available from American Type Culture
Collection), or M. tuberculosis CDC1551 (kindly provided by
Barry Kriesworth, Public Health Research Institute, New York, N.Y.).
All three organisms were grown in suspension culture in Proskauer and
Beck medium containing 0.01% Tween 80 and were harvested while in
log-phase growth. The cultures were subjected to two 5-s bursts of
ultrasound to break up clumps and passed through a 5-µm-pore-size
filter (Gelman Sciences, Ann Arbor, Mich.) to ensure that differences
in virulence could not be attributed to differences in the number of
bacilli per CFU. At 1, 10, 20, 50, and 120 days, five mice infected
with each organism were sacrificed and their lungs, livers, and spleens
were removed and homogenized in phosphate-buffered saline-Tween. The
homogenates were subjected to 10-fold serial dilution, the dilutions
were plated on 7H11 agar, and the plates were incubated for 2 to 3 weeks. Colonies were counted with the aid of a dissecting microscope.
It can be seen in Fig. 1 that strains
CDC1551, H37Rv, and Ravenel multiplied at essentially the same
rates in the lungs of mice over the first 20 days of infection, after
which infection in each case was controlled and caused to plateau at a
level of about 6.5 logs for the duration of the experiment. It can also be seen that these strains caused similar levels of infection in the
liver and spleen. In all cases, infection was not detected in these
organs until day 20 and remained approximately stationary in both
organs from day 20 on. However, in spite of the fact that all three
pathogens gave rise to the same level of infection, Ravenel proved much
more virulent than the other two strains, according to host survival.
The survival curves (Fig. 2) for 10 mice
infected as described above with each of the three strains shows that
Ravenel caused mice to die, with a median survival time of 115 days.
Moreover, all mice infected with this pathogen died before any mice
infected with H37Rv or CDC1551 succumbed. The basis for the differences
in survival times can be deduced from the macroscopic appearance (Fig.
3) of lungs harvested on day 120 of
infection, when more than 50% of mice infected with Ravenel were dead.
It can be seen that lung disease in Ravenel-infected mice was much more
extensive than that in H37Rv-infected mice, which appeared more
extensive, in turn, than lung disease in CDC1551-infected mice. Because
there was no macroscopic pathology evident in other major organs of
mice infected with any one of the pathogens, it seems reasonable to
suggest that all three pathogens caused lung disease but that Ravenel
caused lung disease to develop most rapidly. The possibility that
Ravenel is more pathogenic because it induces the macrophages in which
it resides to secrete more proinflammatory cytokines needs
consideration.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Growth Rate of Mycobacteria in Mice as an
Unreliable Indicator of Mycobacterial Virulence
![]()
ABSTRACT
Top
Abstract
Introduction
References
![]()
INTRODUCTION
Top
Abstract
Introduction
References

View larger version (18K):
[in a new window]
FIG. 1.
Time course of infection with CDC1551, H37Rv, and
Ravenel in C57BL/6 mice infected via the respiratory route with
approximately 102 CFU. The strains were almost identical in
their ability to grow in the organs of mice. Means for five mice per
group per time point ± standard deviations are shown.

View larger version (12K):
[in a new window]
FIG. 2.
Survival of times of 10 mice infected by aerosol with
102 CFU of CDC1551, H37Rv, or Ravenel. Mice infected with
Ravenel died with a median survival time of 115 days. The experiment
was terminated before mice infected with the other strains had all
died.

View larger version (70K):
[in a new window]
FIG. 3.
Appearance of the lungs of mice infected by aerosol with
approximately 102 CFU of CDC1551 (right), H37Rv (left), or
Ravenel (center) on day 120 of infection. Ravenel caused the most lung
pathology, followed in turn by H37Rv and CDC1551.
The ability of mice to cause M. tuberculosis infection to become stationary in their lungs and other organs after the onset of expression of immunity has been stressed in earlier publications from this laboratory (6, 8). Guinea pigs also acquire the ability to stabilize infection in their lungs after several weeks of progressive M. tuberculosis growth (1). It has been suggested that the peculiar susceptibility of the lungs of mice to infection-induced disease makes mouse tuberculosis similar to tuberculosis in humans, because in over 85% of infected humans the disease is confined to the lungs (4). The confinement of disease to the lungs in humans, and in mice, undoubtedly is the result of the acquisition of a state of systemic immunity that is capable of inhibiting disease progression in all organs except the lungs. This is evident from the knowledge that loss of immune competence in mice (3) and humans (2, 5) can result in systemic disease involving multiple organs. It is apparent in the case of mice that although immunity can stabilize infection in the lungs and cause infection to become stationary, the pathogen is able to take advantage of something peculiar to the lungs to induce chronic inflammation and organ consolidation. It is known (3, 11) that in the mouse, chronic lung infection is associated with massive interstitial thickening and fibrosis and that fibrosis is the key manifestation of human pulmonary tuberculosis (16).
We have not attempted to distinguish between the terms pathogenicity and virulence, although a distinction has been made by some (12, 15) and not by others (9, 13). According to one group (10), the extent to which a given M. tuberculosis strain is able to cause pathology in a given period of time is the most useful measure of its virulence. Based on this measure, strain CDC1551 is not a particularly virulent strain of M. tuberculosis, in spite of its highly infectious nature. At this time there seems to be no scientific basis for believing that recently isolated strains are more virulent than long-established reference strains such as H37Rv and Ravenel, which were isolated nearly 100 years ago. It should be pointed out that the C57BL/6 mouse strain employed in this study is considered to be an M. tuberculosis-resistant strain (7).
| |
ADDENDUM |
|---|
After our paper was submitted, an elegant paper by Manca et al. (5a) showing that strain CDC1551 is not more virulent than two other strains of M. tuberculosis, based on mouse survival data, was published.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by grants AI-37844 and AI-40071 from the U.S. Public Health Service and a grant from the G. Harold and Leila Y. Mathers Charitable Foundation.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: The Trudeau Institute, 100 Algonquin Ave., Saranac Lake, NY 12983. Phone: (518) 891-3080. Fax: (518) 891-5126. E-mail: rjnorth{at}northnet.org.
Editor: S. H. E. Kaufmann
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Alsaadi, A.-I., and D. W. Smith. 1975. The fate of virulent and attenuated mycobacteria in guinea pigs infected by the respiratory route. Am. Rev. Respir. Dis. 107:1041-1046. |
| 2. | Barnes, P., A. B. Block, P. T. Davidson, and D. E. Snider. 1991. Tuberculosis in patients with immunodeficiency virus infection. N. Engl. J. Med. 324:1644-1650[Medline]. |
| 3. | Dunn, P. L., and R. J. North. 1995. Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology and cause mortality in mice. Infect. Immun. 63:3428-3437[Abstract]. |
| 4. |
Farer, L. S.
1997.
Extrapulmonary tuberculosis in the United States.
Am. J. Epidemiol.
109:205-211 |
| 5. | Hill, R. A., S. Pemkuma, S. Brustein, K. Vaidya, S. Powell, P.-W. Li, and B. Suster. 1991. Disseminated tuberculosis in the acquired immunodeficiency syndrome era. Am. Rev. Respir. Dis. 144:1164-1170[Medline]. |
| 5a. |
Manca, C.,
L. Tsenova,
C. E. Barry III,
A. Bergtold,
S. Freeman,
P. A. Haslett,
J. M. Musser,
V. H. Freedman, and G. Kaplan.
1999.
Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates.
J. Immunol.
162:6740-6746 |
| 6. |
Medina, E., and R. J. North.
1996.
Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance to infection with Mycobacterium tuberculosis.
J. Exp. Med.
183:1045-1051 |
| 7. | Medina, E., and R. J. North. 1998. Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility haplotype and Nramp1 genotype. Immunology 83:270-274. |
| 8. | Medina, E., and R. J. North. 1999. Genetically susceptible mice remain proportionally more susceptible to tuberculosis after vaccination. Immunology 96:16-21[Medline]. |
| 9. | Mims, C. A. 1982. The pathogenesis of infectious disease, 2nd ed., p. 238-241. Academic Press, Inc., New York, N.Y. |
| 10. | Mitchison, D. A., L. A. Bhatia, S. Radhakrishna, J. B. Selkon, T. V. Subaiah, and J. G. Wallace. 1961. The virulence in the guinea pig of tubercle bacilli isolated before treatment from south Indian patients with pulmonary tuberculosis. 1. Homogeneity of the investigation and a critique of the virulence test. Bull. W. H. O. 25:285-312. |
| 11. | Rhoades, E. R., A. A. Frank, and I. M. Orme. 1997. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuberc. Lung Dis. 78:57-66[Medline]. |
| 12. | Rich, A. R. 1944. Pathogenesis of tuberculosis, p. 80-101. Charles C. Thomas, Publisher, Springfield, Ill. |
| 13. | Salyers, A. A., and D. D. Whitt. 1994. Bacterial pathogenesis: a molecular approach, p. 31-32. ASM Press, Washington, D.C. |
| 14. |
Valway, S. E.,
M. P. C. Sanchez,
T. F. Shinnick,
I. Orme,
T. Agerton,
D. Hoy,
J. S. Jones,
H. Westmoreland, and I. M. Onorato.
1998.
An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis.
N. Engl. J. Med.
338:633-639 |
| 15. | Wilson, G. S., and A. Miles. 1975. Topley and Wilson's principles of bacteriology, virology and immunity, 6th ed., vol. 2. , p. 275-279. Edward Arnold Ltd., London, United Kingdom. |
| 16. | Yeager, H., N. Azumi, and C. B. Underhill. 1996. Fibrosis: the formation of the granuloma matrix, p. 363-370. In W. N. Rom, and S. Garay (ed.), Tuberculosis. Little, Brown & Co., New York, N.Y. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»